Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Antonini

Showing results (81-90 of 495) with videos related to

Pageof 50
Sort By:
CNS Drugs|January 22, 2010
Oral and infusion levodopa-based strategies for managing motor complications in patients with Parkinson's diseaseAngelo Antonini, K Ray Chaudhuri, Pablo Martinez-Martin, et al.
Parkinsonism & Related Disorders|January 15, 2015
Global long-term study on motor and non-motor symptoms and safety of levodopa-carbidopa intestinal gel in routine care of advanced Parkinson's disease patients; 12-month interim outcomesAngelo Antonini, Ashley Yegin, Cornelia Preda, et al.
International Review of Neurobiology|May 31, 2017
Device-Aided Treatment Strategies in Advanced Parkinson's DiseaseJonathan Timpka, Bianca Nitu, Veronika Datieva, et al.
Parkinsonism & Related Disorders|July 30, 2025
Cognitive outcomes of infusion therapies in Parkinson's disease: A comprehensive systematic reviewMichela Garon, Monica Scharfenort, Angelo Antonini, et al.
Functional Neurology|February 14, 2013
Continuous intestinal infusion of levodopa/carbidopa in advanced Parkinson's disease: efficacy, safety and patient selectionGiovanni Abbruzzese, Paolo Barone, Ubaldo Bonuccelli, et al.
Parkinsonism & Related Disorders|March 4, 2014
Reasons for hospitalization in Parkinson's disease: a case-control studyMassimiliano Braga, Massimo Pederzoli, Angelo Antonini, et al.
Journal of the Neurological Sciences|July 30, 2025
Reply: Immersive virtual reality for cognitive training in Parkinson's disease - Future directions and neuroimaging perspectivesEleonora Fiorenzato, Silvia Zabberoni, Alberto Costa, et al.
Expert Review of Neurotherapeutics|June 27, 2023
Objective measurement versus clinician-based assessment for Parkinson's diseaseAndrea Guerra, Valentina D'Onofrio, Florinda Ferreri, et al.
Functional Neurology|July 15, 2010
Rotigotine transdermal patch in the management of Parkinson's disease (PD) and its night-time use for PD-related sleep disordersAngelo Antonini, Laura Bernardi, Daniela Calandrella, et al.
BMJ (Clinical Research Ed.)|December 16, 2015
"Gunslinger's gait": a new cause of unilaterally reduced arm swingRui Araújo, Joaquim J Ferreira, Angelo Antonini, et al.
Pageof 50

Showing results (81-90 of 495) with videos related to

Sort By:
Pageof 50
CNS Drugs|January 22, 2010
Oral and infusion levodopa-based strategies for managing motor complications in patients with Parkinson's diseaseAngelo Antonini, K Ray Chaudhuri, Pablo Martinez-Martin, et al.
Parkinsonism & Related Disorders|January 15, 2015
Global long-term study on motor and non-motor symptoms and safety of levodopa-carbidopa intestinal gel in routine care of advanced Parkinson's disease patients; 12-month interim outcomesAngelo Antonini, Ashley Yegin, Cornelia Preda, et al.
International Review of Neurobiology|May 31, 2017
Device-Aided Treatment Strategies in Advanced Parkinson's DiseaseJonathan Timpka, Bianca Nitu, Veronika Datieva, et al.
Parkinsonism & Related Disorders|July 30, 2025
Cognitive outcomes of infusion therapies in Parkinson's disease: A comprehensive systematic reviewMichela Garon, Monica Scharfenort, Angelo Antonini, et al.
Functional Neurology|February 14, 2013
Continuous intestinal infusion of levodopa/carbidopa in advanced Parkinson's disease: efficacy, safety and patient selectionGiovanni Abbruzzese, Paolo Barone, Ubaldo Bonuccelli, et al.
Parkinsonism & Related Disorders|March 4, 2014
Reasons for hospitalization in Parkinson's disease: a case-control studyMassimiliano Braga, Massimo Pederzoli, Angelo Antonini, et al.
Journal of the Neurological Sciences|July 30, 2025
Reply: Immersive virtual reality for cognitive training in Parkinson's disease - Future directions and neuroimaging perspectivesEleonora Fiorenzato, Silvia Zabberoni, Alberto Costa, et al.
Expert Review of Neurotherapeutics|June 27, 2023
Objective measurement versus clinician-based assessment for Parkinson's diseaseAndrea Guerra, Valentina D'Onofrio, Florinda Ferreri, et al.
Functional Neurology|July 15, 2010
Rotigotine transdermal patch in the management of Parkinson's disease (PD) and its night-time use for PD-related sleep disordersAngelo Antonini, Laura Bernardi, Daniela Calandrella, et al.
BMJ (Clinical Research Ed.)|December 16, 2015
"Gunslinger's gait": a new cause of unilaterally reduced arm swingRui Araújo, Joaquim J Ferreira, Angelo Antonini, et al.
Pageof 50